AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The incidence of early-onset neonatal group B streptococcal disease in the United States has dropped by a third since guidelines for universal screening of pregnant women were issued, the Centers for Disease Control and Prevention reported.
The guidelines, which call for routine screening of pregnant women for rectovaginal group B streptococcal (GBS) colonization at 35-37 weeks' gestation and administration of intrapartum antimicrobial prophylaxis to carriers, were jointly issued in 2002 by the American College of Obstetricians and Gynecologists, the American Academy of Pediatrics, and the CDC (MMWR Recomm. Rep. 2002;51[RR-11]:1-22).
In 2004, the incidence of GBS disease in newborns aged 0-6 days (early-onset disease) had decreased by 31% from the period of 2000-2001, immediately before universal screening was implemented, the CDC said (MMWR 2005;54:1205-8).
Late-onset GBS disease--occurring in infants aged 7-89 days--did not change during 1996-2004, the period for which data were analyzed from the CDC's Active Bacterial Core surveillance (ABCs) system. The ABCs areas represented approximately 337,000 live births in 1996 and 427,000 live births in 2004. A total of 308 ...
Source: HighBeam Research, Early-onset group B strep down 31% in 2004.(Obstetrics)